<DOC>
	<DOC>NCT01030406</DOC>
	<brief_summary>The primary objective of this study is to compare the relative abuse potential of two different doses of orally administered Acurox Tablets to orally administered immediate-release (IR) oxycodone HCl tablets in non-dependent recreational opioid users.</brief_summary>
	<brief_title>Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users</brief_title>
	<detailed_description />
	<criteria>Subject is male or female between 18 and 55 years old. Subject is in generally good health, including no history of pulmonary disease, and has a body mass index (BMI) within 1833 kg/m2. Subject is a recreational opioid user (i.e., at least 10 occasions within the past 12 months, and at least 1 within the past 12 weeks) who is NOT physically dependent on opioids (per Diagnostic and Statistical Manual of Mental DisordersFourth EditionText Revision [DSMIVTR]); is able to speak, read, and understand English; and will provide written informed consent. Subject has a minimum of a 6th grade reading level as determined by the Investigator or by the Rapid Estimation of Adult Literacy in Medicine (REALM). History or current diagnosis of substance dependence (except nicotine and caffeine) and/or alcohol abuse according to the criteria of DSMIVTR. History or current diagnosis of neurological, hepatic, renal, endocrine, cardiovascular, gastrointestinal, hematologic, pulmonary, or metabolic disease. Known allergy or history of hypersensitivity to oxycodone HCl, other opioids, or any component of Acurox Tablets.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Abuse Liability</keyword>
	<keyword>Abuse Prevention</keyword>
	<keyword>Abuse Resistance</keyword>
	<keyword>Abuse Deterrence</keyword>
</DOC>